Medistim ASA Statistics

Total Valuation

Medistim ASA has a market cap or net worth of NOK 2.96 billion. The enterprise value is 2.81 billion.

Market Cap	2.96B
Enterprise Value	2.81B

Important Dates

The last earnings date was Tuesday, April 8, 2025.

Earnings Date	Apr 8, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Medistim ASA has 18.25 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	n/a
Shares Outstanding	18.25M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	+0.27%
Owned by Insiders (%)	2.82%
Owned by Institutions (%)	95.09%
Float	12.64M

Valuation Ratios

The trailing PE ratio is 28.57 and the forward PE ratio is 28.27.

PE Ratio	28.57
Forward PE	28.27
PS Ratio	5.32
PB Ratio	6.77
P/TBV Ratio	7.84
P/FCF Ratio	21.57
P/OCF Ratio	20.66
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.07, with an EV/FCF ratio of 20.51.

EV / Earnings	27.08
EV / Sales	5.05
EV / EBITDA	18.07
EV / EBIT	21.45
EV / FCF	20.51

Financial Position

The company has a current ratio of 4.00, with a Debt / Equity ratio of 0.08.

Current Ratio	4.00
Quick Ratio	2.41
Debt / Equity	0.08
Debt / EBITDA	0.22
Debt / FCF	0.25
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 24.88% and return on invested capital (ROIC) is 18.48%.

Return on Equity (ROE)	24.88%
Return on Assets (ROA)	15.16%
Return on Invested Capital (ROIC)	18.48%
Return on Capital Employed (ROCE)	28.03%
Revenue Per Employee	3.61M
Profits Per Employee	674,234
Employee Count	151
Asset Turnover	1.03
Inventory Turnover	0.74

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.67% in the last 52 weeks. The beta is 1.06, so Medistim ASA's price volatility has been similar to the market average.

Beta (5Y)	1.06
52-Week Price Change	-12.67%
50-Day Moving Average	169.34
200-Day Moving Average	163.18
Relative Strength Index (RSI)	42.37
Average Volume (20 Days)	7,182

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medistim ASA had revenue of NOK 556.16 million and earned 103.83 million in profits. Earnings per share was 5.67.

Revenue	556.16M
Gross Profit	442.48M
Operating Income	131.08M
Pretax Income	134.25M
Net Income	103.83M
EBITDA	146.80M
EBIT	131.08M
Earnings Per Share (EPS)	5.67

Full Income Statement

Balance Sheet

The company has 179.21 million in cash and 34.36 million in debt, giving a net cash position of 144.85 million or 7.94 per share.

Cash & Cash Equivalents	179.21M
Total Debt	34.36M
Net Cash	144.85M
Net Cash Per Share	7.94
Equity (Book Value)	436.61M
Book Value Per Share	23.84
Working Capital	321.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 143.10 million and capital expenditures -6.07 million, giving a free cash flow of 137.04 million.

Operating Cash Flow	143.10M
Capital Expenditures	-6.07M
Free Cash Flow	137.04M
FCF Per Share	7.51

Full Cash Flow Statement

Margins

Gross margin is 79.56%, with operating and profit margins of 23.57% and 18.67%.

Gross Margin	79.56%
Operating Margin	23.57%
Pretax Margin	24.14%
Profit Margin	18.67%
EBITDA Margin	26.39%
EBIT Margin	23.57%
FCF Margin	24.64%

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 3.70%.

Dividend Per Share	6.00
Dividend Yield	3.70%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	n/a
Payout Ratio	79.37%
Buyback Yield	-0.10%
Shareholder Yield	3.60%
Earnings Yield	3.51%
FCF Yield	4.64%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medistim ASA has an Altman Z-Score of 17.36.

Altman Z-Score	17.36
Piotroski F-Score	n/a